Chimerix to Announce Third Quarter 2018 Financial Results on November 8, 2018
November 01 2018 - 8:00AM
Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing
novel antivirals to address life-threatening viral
infections, today announced that it will host a live
conference call and audio webcast on Thursday, November 8, 2018 at
8:30 a.m. ET to report financial results for the third quarter
ended September 30, 2018, and to provide a business overview.
To access the live conference call, please dial (877) 354-4056
(domestic) or (678) 809-1043 (international) at least five minutes
prior to the start time, and refer to conference ID 4646308. A live
audio webcast of the call will also be available on the Investors’
section of the Company's website, www.chimerix.com. An archived
webcast will be available on the Chimerix website approximately two
hours after the event.
About ChimerixChimerix is a
biopharmaceutical company dedicated to discovering, developing and
commercializing medicines that improve outcomes for
immunocompromised patients. Chimerix's proprietary lipid
conjugate technology and compound library have produced
brincidofovir (BCV, CMX001); CMX157, which was licensed
to ContraVir Pharmaceuticals; and CMX521, the first
clinical-stage direct-acting antiviral for the treatment and
prevention of norovirus. For further information, please
visit Chimerix's website, www.chimerix.com.
CONTACT:Investor Relations:Michelle
LaSpaluto(919) 972-7115ir@chimerix.comorWill O’ConnorStern Investor
RelationsWill@sternir.com(212) 362-1200
Media: Laurie Masonson W2O Group lmasonson@w2ogroup.com (917)
459-6164
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024